Dr. Matthias Karajannis, MD, MS
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Neurofibromatosis
Matthias Karajannis, MD, MS has run 3 trials for Neurofibromatosis. Some of their research focus areas include:
Brain Cancer
Matthias Karajannis, MD, MS has run 2 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Clinical Trials Matthias Karajannis, MD, MS is currently running
More about Matthias Karajannis, MD, MS
Clinical Trial Related
6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Matthias Karajannis, MD, MS has experience with
- Temozolomide
- Bevacizumab
- Irinotecan
- Omburtamab I-131
- INCB7839
- Radiation Therapy
Breakdown of trials Matthias Karajannis, MD, MS has run
Neurofibromatosis
Brain Cancer
Glioblastoma
Astrocytoma
Diffuse Hemispheric Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthias Karajannis, MD, MS specialize in?
Matthias Karajannis, MD, MS focuses on Neurofibromatosis and Brain Cancer. In particular, much of their work with Neurofibromatosis has involved NF2 positive patients, or patients who are NF1 positive.
Is Matthias Karajannis, MD, MS currently recruiting for clinical trials?
Yes, Matthias Karajannis, MD, MS is currently recruiting for 1 clinical trial in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Matthias Karajannis, MD, MS has studied deeply?
Yes, Matthias Karajannis, MD, MS has studied treatments such as Temozolomide, Bevacizumab, Irinotecan.
What is the best way to schedule an appointment with Matthias Karajannis, MD, MS?
Apply for one of the trials that Matthias Karajannis, MD, MS is conducting.
What is the office address of Matthias Karajannis, MD, MS?
The office of Matthias Karajannis, MD, MS is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.